Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261976 · ClinicalTrials.gov registry record
A Long-term Safety Study of Infliximab (Remicade)
A clinical trial, sponsored by Centocor.
- Completed
- Registry status
- 2,971
- Enrollment target
NCT00261976: Completed study, sponsored by Centocor.
NCT00261976 is a clinical trial that has completed, run by Centocor. The registered enrollment target is 2,971 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00261976 has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- 2,971 participants
- Enrollment target
Study Summary
This is a study evaluating the long-term safety of infliximab (Remicade)
Primary Outcome
Number of patients with each of the following long-term safety events: serious infections, new malignancies, new autoimmune diseases, death, or delayed hypersensitivity (serum sickness-like) reactions.
Interventions
- DRUG Infliximab (Remicade)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,971 participants |
| Start Date | 2002-02 |
| Est. Completion | 2012-03 |
What the finished NCT00261976 record still lists
NCT00261976 is an observational study that tracks outcomes without assigning an intervention. Its 2,971 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Infliximab (Remicade) is the first listed.
NCT00261976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00261976 about?
NCT00261976 is a clinical study titled "A Long-term Safety Study of Infliximab (Remicade)". This is a study evaluating the long-term safety of infliximab (Remicade)
What is the current status of trial NCT00261976?
This trial is currently completed. The enrollment target is 2,971 participants. The study started on 2002-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00261976?
The interventions under investigation include: Infliximab (Remicade) (DRUG).
Who is sponsoring clinical trial NCT00261976?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03331380 · 2,950 participants · NA
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
- NCT05297734 · 2,996 participants · NA
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- NCT05849961 · 2,946 participants
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
- NCT03860883 · 2,998 participants · NA
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia